Mavyret — Medical Mutual
Recurrent Hepatitis C Virus (HCV) Post-Liver Transplantation, Genotype 1, 2, 3, 4, 5, or 6
Initial criteria
- Patient age ≥ 3 years
- Patient has recurrent HCV after liver transplant
- Prescribed by or in consultation with affiliated transplant specialist (gastroenterologist, hepatologist, infectious diseases physician, or liver transplant physician)
Approval duration
12 weeks